
BiotechTV - News Jefferies London: Zymeworks had double-news during London Life Science Week - a P3 success for its HER2 bispecific in gastroesophageal cancer and it also launched a new royalty model
Nov 18, 2025
Chapters
Transcript
Episode notes
